Infinity cuts 20% of workforce as it refocuses on PI3K and retaspimycin
This article was originally published in Scrip
Executive Summary
Infinity Pharmaceuticals revealed in its second quarter 2012 financial report that it cut 20% of its workforce - 40 employees at the company's Cambridge, Massachusetts headquarters - after shutting down its Hedgehog pathway programme and renegotiating its partnership with Mundipharma International.